{"id":"97a7c2a5-da52-5b3e-a977-e42afe014073","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-dose-escalation-fails","predicate":"limits","statement":"Absorption of oral flubendazole in man was markedly enhanced when the drug was taken together with a meal, but a twenty times higher dose produced only an increase by a factor of 1.4 in plasma levels and area under the curve, indicating that absorption is limited by the extremely poor solubility of the drug in the contents of the gastrointestinal tract; in rats plasma levels of oral and subcutaneous mebendazole were about ten times higher than those of flubendazole.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"486c1204-0ed3-5319-8d00-a8ae41aa6423","mechanism_event_label":"Twenty times the dose gave less than half again as much in the blood, because it simply will not dissolve.","subject":{"id":"eeb5e0c0-e626-5e40-b6c2-0b797bc7e279","slug":"flubendazole","display_name":"Flubendazole","entity_type_key":"drug"},"object":{"id":"c42f1791-ecdc-584a-b45d-99dc23ededff","slug":"oral-bioavailability","display_name":"Oral bioavailability","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"486c1204-0ed3-5319-8d00-a8ae41aa6423","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-dose-escalation-fails-event","event_type":"observed_intervention","label":"Twenty times the dose gave less than half again as much in the blood, because it simply will not dissolve.","description":"Absorption of oral flubendazole in man was markedly enhanced when the drug was taken together with a meal, but a twenty times higher dose produced only an increase by a factor of 1.4 in plasma levels and area under the curve, indicating that absorption is limited by the extremely poor solubility of the drug in the contents of the gastrointestinal tract; in rats plasma levels of oral and subcutaneous mebendazole were about ten times higher than those of flubendazole.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"bd95c09d-7613-5fed-b54a-b918e25f6551","slug":"aqueous-solubility","display_name":"Aqueous solubility and dissolution rate of the solid drug","entity_type_key":"cellular_process"},"role":"limiting_property","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"bbf29d55-a2b1-5d88-9b19-c96e62ce1771","slug":"fatty-meal","display_name":"A meal containing fat, taken with the dose","entity_type_key":"chemical_species"},"role":"enhancing_factor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"f8582a13-fc2e-5127-a61f-5b0594e54069","slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"},"role":"better_absorbed_relative","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"eeb5e0c0-e626-5e40-b6c2-0b797bc7e279","slug":"flubendazole","display_name":"Flubendazole","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"c42f1791-ecdc-584a-b45d-99dc23ededff","slug":"oral-bioavailability","display_name":"Oral bioavailability","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/mebendazole-research/7103610.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e582dcb4657e254dfe61d437d899b2db4d2a4628aa1267fb90de6366b7b4c8f0\", \"start_char\": 0, \"end_char\": 948, \"text_sha256\": \"e582dcb4657e254dfe61d437d899b2db4d2a4628aa1267fb90de6366b7b4c8f0\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Radioimmunoassay of mebendazole and flubendazole across rats, dogs and man","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Oral, subcutaneous and intramuscular dosing, and a twentyfold oral dose escalation of flubendazole in man","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The dose-escalation arm is about flubendazole rather than mebendazole, and is recorded under flubendazole; it is retained because it demonstrates the solubility limit that governs this whole class.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.","comparator":null,"unit":null,"notes":"","entity":{"slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Rat, dog and human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Twenty times the dose gave less than half again as much in the blood, because it simply will not dissolve.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[mbz-p7103610] The pharmacokinetics of mebendazole and flubendazole in animals and man. (1982). https://pubmed.ncbi.nlm.nih.gov/7103610/","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Plasma","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"bfe26738-03d0-5db7-98cd-64f629558730","evidence_kind":"source_excerpt","locator":"Lines 459-470","start_line":459,"end_line":470,"excerpt":"### mbz-dose-escalation-fails\nAbsorption of oral flubendazole in man was markedly enhanced when the drug was taken together with a meal, but a twenty times higher dose produced only an increase by a factor of 1.4 in plasma levels and area under the curve, indicating that absorption is limited by the extremely poor solubility of the drug in the contents of the gastrointestinal tract; in rats plasma levels of oral and subcutaneous mebendazole were about ten times higher than those of flubendazole.\nCondition category: normal\nnutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.\nplain_language: Twenty times the dose gave less than half again as much in the blood, because it simply will not dissolve.\norganism: Rat, dog and human\ntissue_or_cell_type: Plasma\nexperimental_model: Radioimmunoassay of mebendazole and flubendazole across rats, dogs and man\nlimitations: The dose-escalation arm is about flubendazole rather than mebendazole, and is recorded under flubendazole; it is retained because it demonstrates the solubility limit that governs this whole class.\nexposure: Oral, subcutaneous and intramuscular dosing, and a twentyfold oral dose escalation of flubendazole in man\nevidence_span: {\"source_cache\": \"artifacts/mebendazole-research/7103610.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e582dcb4657e254dfe61d437d899b2db4d2a4628aa1267fb90de6366b7b4c8f0\", \"start_char\": 0, \"end_char\": 948, \"text_sha256\": \"e582dcb4657e254dfe61d437d899b2db4d2a4628aa1267fb90de6366b7b4c8f0\"}\n[mbz-p7103610] The pharmacokinetics of mebendazole and flubendazole in animals and man. (1982). https://pubmed.ncbi.nlm.nih.gov/7103610/","model_system":"Radioimmunoassay of mebendazole and flubendazole across rats, dogs and man","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [mbz-p7103610] The pharmacokinetics of mebendazole and flubendazole in animals and man. (1982). https://pubmed.ncbi.nlm.nih.gov/7103610/","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"06104773-03d0-5e5c-b9da-eb484e7be657","stable_key":"import-f2ec2007-88ff-5a96-a73b-8b5085e9cea9","title":"Mebendazole: the tubulin it binds, why that is selective, the crystal form that decides whether any of it works, and the off-target that became an oncology programme (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"58b652636677e5033fd1dd555744485fcef18f21a97dcf68723fe072b656f413","revision_id":"a2cd9c22-0549-52ca-a653-8a0c2362ec85","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}